Immucell Corp /DE/ SEC filings ICCC

Immucell Corp /DE/ has 795 filings in SEC EDGAR's recent list, going back to Aug 3, 1995. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (results of operations). The company's fiscal year ends on December 31.

Immucell Corp /DE/ SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Oct 13, 2026 Oct 12, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Results of operations
Jul 9, 2026 Jul 9, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
8-K Current report
Shareholder vote results
Jun 17, 2026 Jun 11, 2026
8-K Current report
Regulation FD disclosure
Jun 10, 2026 Jun 4, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
10-K/A Amended annual report May 13, 2026 Dec 31, 2025
8-K Current report
Material agreement
May 8, 2026 May 8, 2026
DEF 14A Proxy statement Apr 24, 2026 Jun 11, 2026
3 Initial insider ownership Apr 23, 2026 Apr 15, 2026
3 Initial insider ownership Apr 23, 2026 Apr 15, 2026
4 Insider transaction Apr 16, 2026 Apr 15, 2026
4 Insider transaction Apr 16, 2026 Apr 15, 2026
4 Insider transaction Apr 16, 2026 Apr 15, 2026
4 Insider transaction Apr 16, 2026 Apr 15, 2026
PRE 14A Preliminary proxy statement Apr 14, 2026 Jun 11, 2026
4 Insider transaction Apr 14, 2026 Apr 16, 2025
4 Insider transaction Apr 14, 2026 Apr 16, 2025
4 Insider transaction Apr 14, 2026 Apr 16, 2025
4 Insider transaction Apr 14, 2026 Apr 16, 2025
4 Insider transaction Apr 14, 2026 Apr 16, 2025
4 Insider transaction Apr 14, 2026 Apr 16, 2025
8-K Current report
Officer or director change, Other events
Apr 14, 2026 Apr 7, 2026
8-K Current report
Results of operations
Apr 8, 2026 Apr 8, 2026
3 Initial insider ownership Apr 1, 2026 Apr 1, 2026
10-K Annual report Mar 30, 2026 Dec 31, 2025
4 Insider transaction Mar 24, 2026 Mar 20, 2026
4/A Form 4a Mar 23, 2026 Jan 27, 2026
8-K Current report
Officer or director change
Mar 18, 2026 Mar 12, 2026
8-K Current report
Results of operations
Mar 4, 2026 Mar 4, 2026
8-K Current report
Officer or director change
Feb 9, 2026 Feb 9, 2026
8-K Current report
Material agreement, Officer or director change
Feb 2, 2026 Jan 27, 2026
4 Insider transaction Jan 29, 2026 Jan 27, 2026
4 Insider transaction Jan 29, 2026 Jan 27, 2026
4 Insider transaction Jan 29, 2026 Jan 27, 2026
8-K Current report
Results of operations, Impairment, Other events
Jan 8, 2026 Jan 8, 2026
8-K Current report
Impairment, Other events
Dec 29, 2025 Dec 24, 2025
4/A Form 4/a olivier te boekhorst Dec 4, 2025 Dec 3, 2025
4 Insider transaction Dec 3, 2025 Dec 2, 2025
4 Insider transaction Nov 28, 2025 Nov 25, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 20, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
4 Insider transaction Nov 12, 2025 Nov 7, 2025
3 Initial insider ownership Nov 7, 2025 Oct 29, 2025
8-K Current report
Officer or director change
Nov 4, 2025 Oct 29, 2025
8-K Current report
Results of operations
Oct 7, 2025 Oct 7, 2025
8-K Current report
Material agreement, Officer or director change
Sep 30, 2025 Sep 29, 2025
8-K Current report
Material agreement, New debt
Aug 25, 2025 Aug 20, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Material agreement, New debt
Aug 12, 2025 Aug 7, 2025
8-K Current report
Results of operations
Jul 9, 2025 Jul 9, 2025
8-K Current report
Other events
Jun 25, 2025 Jun 25, 2025
8-K Current report
Shareholder vote results
Jun 17, 2025 Jun 12, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 12, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
DEF 14A Proxy statement Apr 24, 2025 Jun 12, 2025
4 Insider transaction Apr 23, 2025 Apr 16, 2025
8-K Current report
Results of operations
Apr 8, 2025 Apr 8, 2025
3 Initial insider ownership Apr 7, 2025 Apr 7, 2025
8-K Current report
Material agreement, Officer or director change
Apr 7, 2025 Apr 4, 2025
10-K Annual report Mar 28, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 25, 2025 Feb 25, 2025
8-K Current report
Other events
Jan 16, 2025 Jan 16, 2025
8-K Current report
Results of operations
Jan 10, 2025 Jan 9, 2025
8-K Current report
Material agreement, Agreement ended, Officer or director change
Dec 9, 2024 Dec 6, 2024
8-K Current report
Material agreement
Dec 2, 2024 Nov 29, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
8-K Current report
Results of operations
Oct 8, 2024 Oct 8, 2024
8-K Current report
Material agreement, New debt, Bylaw or fiscal year change
Sep 24, 2024 Sep 20, 2024
4 Insider transaction Sep 24, 2024 Sep 20, 2024
4 Insider transaction Sep 24, 2024 Sep 20, 2024
4 Insider transaction Sep 24, 2024 Sep 20, 2024
4 Insider transaction Sep 24, 2024 Sep 20, 2024
4 Insider transaction Sep 24, 2024 Sep 20, 2024
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 17, 2024 —
4 Insider transaction Aug 30, 2024 Aug 28, 2024
SC 13D Ownership over 5% (active) Aug 27, 2024 —
4 Insider transaction Aug 26, 2024 Aug 23, 2024
4 Insider transaction Aug 22, 2024 Aug 22, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
8-K Current report
Results of operations
Jul 9, 2024 Jul 9, 2024
8-K Current report
Material agreement, New debt
Jun 14, 2024 Jun 11, 2024
8-K Current report
Shareholder vote results
Jun 14, 2024 Jun 13, 2024
8-K Current report
Other events
Jun 6, 2024 Jun 5, 2024
SCHEDULE 13D Ownership over 5% (active) May 22, 2024 —
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
DEF 14A Proxy statement Apr 26, 2024 Jun 13, 2024
424B2 Prospectus Apr 10, 2024 —
424B2 Prospectus Apr 10, 2024 —
EFFECT Filing Apr 9, 2024 —
8-K Current report
Material agreement
Apr 9, 2024 Apr 8, 2024
8-K Current report
Results of operations
Apr 9, 2024 Apr 9, 2024
CORRESP Letter to the SEC Apr 5, 2024 —
UPLOAD Letter from the SEC Apr 5, 2024 —
S-3 Shelf registration Apr 1, 2024 —
10-K Annual report Apr 1, 2024 Dec 31, 2023
8-K Current report
Material agreement
Mar 6, 2024 Mar 4, 2024
8-K Current report
Material agreement, New debt
Feb 27, 2024 Feb 22, 2024
8-K Current report
Results of operations
Feb 27, 2024 Feb 27, 2024
8-K Current report
Results of operations
Jan 8, 2024 Jan 8, 2024
8-K Current report
Material agreement, New debt
Nov 16, 2023 Nov 14, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
8-K Current report
Results of operations
Oct 5, 2023 Oct 5, 2023
4 Insider transaction Sep 6, 2023 Sep 6, 2023
4 Insider transaction Aug 30, 2023 Jun 28, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
8-K Current report
Material agreement, New debt
Jul 21, 2023 Jul 17, 2023
S-8 Employee stock plan registration Jul 13, 2023 —
8-K Current report
Results of operations
Jul 11, 2023 Jul 11, 2023
8-K Current report
Regulation FD disclosure
Jun 29, 2023 Jun 28, 2023
3 Initial insider ownership Jun 21, 2023 Jun 16, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 21, 2023 Jun 15, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 28, 2023 Jun 15, 2023
PRE 14A Preliminary proxy statement Apr 18, 2023 Apr 18, 2023
8-K Current report
Results of operations
Apr 5, 2023 Apr 5, 2023
10-K Annual report Mar 29, 2023 Dec 31, 2022
4 Insider transaction Mar 15, 2023 Mar 13, 2023
8-K Current report
Officer or director change
Feb 28, 2023 Feb 23, 2023
8-K Current report
Results of operations
Feb 21, 2023 Feb 21, 2023
8-K Current report
Officer or director change
Feb 1, 2023 Jan 24, 2023
4 Insider transaction Jan 24, 2023 Dec 15, 2022
4 Insider transaction Jan 24, 2023 Dec 15, 2022
4 Insider transaction Jan 24, 2023 Dec 15, 2022
4 Insider transaction Jan 24, 2023 Dec 15, 2022
4 Insider transaction Jan 24, 2023 Dec 15, 2022
3 Initial insider ownership Jan 24, 2023 Jun 10, 2020
8-K Current report
Results of operations
Jan 9, 2023 Jan 9, 2023
8-K Current report
Results of operations
Nov 21, 2022 Nov 21, 2022
10-Q Quarterly report Nov 21, 2022 Sep 30, 2022
10-Q/A Amended quarterly report Nov 21, 2022 Jun 30, 2022
10-Q/A Amended quarterly report Nov 21, 2022 Mar 31, 2022
8-K Current report
Results of operations, Restatement
Nov 10, 2022 Nov 8, 2022
NT 10-Q Notification of late filing Nov 10, 2022 Sep 30, 2022
8-K Current report
Results of operations
Oct 5, 2022 Oct 5, 2022
4 Insider transaction Sep 12, 2022 Sep 8, 2022
8-K Current report
Material agreement, New debt
Aug 17, 2022 Aug 15, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
8-K Current report
Other events
Jul 28, 2022 Jul 27, 2022
8-K Current report
Results of operations
Jul 7, 2022 Jul 7, 2022
8-K/A Amended current report
Shareholder vote results
Jun 21, 2022 Jun 15, 2022
4 Insider transaction Jun 16, 2022 Jun 1, 2022
8-K Current report
Shareholder vote results
Jun 16, 2022 Jun 15, 2022
4 Insider transaction Jun 14, 2022 Jun 13, 2022
4/A Filing May 18, 2022 May 16, 2022
4 Insider transaction May 18, 2022 Feb 11, 2022
4 Insider transaction May 18, 2022 May 16, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
DEF 14A Proxy statement Apr 28, 2022 Jun 15, 2022
PRE 14A Preliminary proxy statement Apr 12, 2022 Apr 12, 2022
8-K Current report
Results of operations
Apr 11, 2022 Apr 11, 2022
10-K Annual report Mar 30, 2022 Dec 31, 2021
8-K Current report
Material agreement, New debt
Mar 24, 2022 Mar 24, 2022
4 Insider transaction Mar 14, 2022 Mar 9, 2022
8-K Current report
Results of operations
Feb 22, 2022 Feb 22, 2022
8-K Current report
Material agreement, Officer or director change
Feb 11, 2022 Feb 11, 2022
4 Insider transaction Feb 9, 2022 Jan 31, 2022
4 Insider transaction Feb 9, 2022 Jan 31, 2022
4 Insider transaction Feb 9, 2022 Jan 31, 2022
8-K Current report
Results of operations
Jan 5, 2022 Jan 5, 2022
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Results of operations
Oct 6, 2021 Oct 6, 2021
8-K Current report
Regulation FD disclosure, Other events
Aug 24, 2021 Aug 24, 2021
10-Q Quarterly report Aug 12, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 12, 2021 Aug 12, 2021
8-K Current report
Results of operations
Jul 7, 2021 Jul 7, 2021
8-K Current report
Material agreement, New debt
Jul 6, 2021 Jun 30, 2021
4 Insider transaction Jun 25, 2021 Jun 17, 2021
4 Insider transaction Jun 21, 2021 Jun 17, 2021
4 Insider transaction Jun 21, 2021 Jun 17, 2021
4 Insider transaction Jun 21, 2021 Jun 17, 2021
4 Insider transaction Jun 21, 2021 Jun 17, 2021
8-K Current report
Shareholder vote results
Jun 17, 2021 Jun 16, 2021
4 Insider transaction Jun 7, 2021 Jun 3, 2021
10-Q Quarterly report May 13, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 13, 2021 May 13, 2021
DEF 14A Proxy statement Apr 29, 2021 Jun 16, 2021
SC 13D/A Amended ownership over 5% (active) Apr 16, 2021 —
424B5 Prospectus supplement Apr 16, 2021 —
8-K Current report
Material agreement
Apr 15, 2021 Apr 14, 2021
8-K Current report
Results of operations
Apr 7, 2021 Apr 7, 2021
10-K Annual report Mar 30, 2021 Dec 31, 2020

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
ICCC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Portland, ME
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
811641

Other In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.